Development and clinical validation of a risk prediction model for incontinence- associated dermatitis (IAD) in a hospitalised adult patient population

People living with incontinence are at risk of developing irritant contact dermatitis; known as incontinence-associated dermatitis (IAD).

IAD is a major health challenge worldwide and a recognised risk factor for developing devastating wounds, such as pressure ulcers. IAD affects over 50% of patients with incontinence.

IAD risk assessment aims to assess risk based on factors that increase (risk factor) or decrease (protective factor) an individual´s susceptibility to developing IAD.

Risk assessment is important for (1) disease prognosis, (2) prioritizing resource use, and (3) informing clinical interventions.

An essential component of the IAD risk assessment process is an IAD risk prediction model.The aims of this project are:to develop the first predictive IAD model in a combined effort including a systematic review and a global Delphi Consensus study,to test the new model clinically in a cohort study in 6 Swedish hospitals, andto evaluate the applicability of the new predictive model in clinical practice in a qualitative study.The risk prediction model will be innovative and inventive, translating evidence on IAD risk factors and expert opinion into a usable tool for clinical practice.

It will help to accurately identify patients who need preventive treatment. It will guide clinical decision making and have a positive impact on the quality of patient care. The tool will also guide decision makers in resource allocation and researchers in designing clinical trials.